Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Viking Therapeutics

Tracked across 2 events · 12 articles · First seen May 08, 2026 · Last active Sep 22, 2026

Sentiment
22
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 40
Business
Impact: Viking Therapeutics is listed among emerging players in the obesity therapeutics market.
May 08, 2026 · 6 articles
4 5
Business
Eli Lilly and Company shares fell roughly 7-8% over the month preceding mid-September 2026, sliding from about $1,255 to around $1,115-1,165, even as the broader S&P 500 advanced. The decline followed realized U.S. price declines…
Impact: Clinical-stage biotech peer cited for its roughly 207% implied upside, reflecting binary trial risk rather than franchise strength. Serves as a contrast to Lilly's cash-generative large-cap setup.
Sep 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Viking Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.